Success Stories: Surgical Pathology Fellow Investigating Molecular Cancer Mechanisms Secured NIW in Just Over a Week With NAILG
Client’s Testimonial:
“I got in touch with North America Immigration Law Group through a referral by a friend who also had a great experience. It was a wonderful experience working with them on my application. They always reply within 24 hours. They provided a high level of guidance as well as attention to detail. They suggested some extra documents based on recent trends. I am so happy for the case approval and want to thank them so much for guiding me through this path. Highly recommend them.”
On April 20th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Surgical Pathology Fellow in the Field of Pathology (Approval Notice).
General Field: Pathology
Position at the Time of Case Filing: Surgical Pathology Fellow
Country of Origin: Pakistan
State of Residence at the Time of Filing: Florida
Approval Notice Date: April 20th, 2025
Processing Time: 9 days (Premium Processing Requested)
Case Summary:
An accomplished pathologist partnered with the North America Immigration Law Group (NAILG) to pursue a National Interest Waiver (NIW) petition based on his groundbreaking work in cancer diagnostics. From the outset, NAILG recognized the national health relevance of his research, which focuses on the advanced histologic, immunologic, and molecular characteristics of malignant tissues, particularly in breast, renal, gastrointestinal, and hematolymphoid neoplasms. Together, they developed a legal strategy that showcased how our client’s research addresses one of the nation’s most urgent challenges: improving early detection and treatment planning for common and often deadly cancers.
His proposed endeavor aims to elevate the accuracy of pathology-based diagnostics using cutting-edge laboratory techniques. By investigating cancer tissues at the molecular level, his research enhances diagnostic precision, supports the discovery of novel treatment strategies, and contributes to early disease detection - a key to improving patient survival. NAILG underscored how his work supports the U.S. healthcare system’s ongoing efforts to reduce cancer burden through innovation in detection and diagnosis.
Our client’s scientific credentials were a core component of the petition. His contributions include 12 peer-reviewed journal articles, 6 abstracts (including 2 first-authored), and 1 book chapter, with his published work having been cited 113 times. He has also served as a peer reviewer for at least 6 academic submissions, further demonstrating his recognition and active participation in the pathology research community.
A letter submitted in support of his petition highlighted the clinical value of his research:
“As a conclusion, [client]'s leadership in pathology is evident with his contributions to breast cancer treatment, particularly through his insights into the impact of TILs on patient survival. There is no doubt that [client] will continue to produce valuable research that drives progress in the field and brings significant benefits to both national and international healthcare.”
Throughout the petition process, NAILG played a critical role in shaping and presenting the evidence to meet USCIS’s standards under the Matter of Dhanasar framework. By emphasizing the substantial merit, national importance, and the clear benefit of waiving labor certification, NAILG successfully secured NIW approval for our client. He is now well-positioned to continue his impactful research in the United States, where his contributions will further enhance cancer diagnostics and patient outcomes nationwide.